Peptide Comparison
Palmitoyl Tetrapeptide-7vsAcetyl Hexapeptide-3 (Argireline)
Anti-inflammatory matrikine peptide that reduces IL-6-driven inflammaging for calmer, more youthful skin.
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
At a Glance
Quick
comparison
Dose Range
Palmitoyl Tetrapeptide-7
0.5%–8% %
Acetyl Hexapeptide-3 (Argireline)
5%–10% %
Frequency
Palmitoyl Tetrapeptide-7
Once daily
Acetyl Hexapeptide-3 (Argireline)
Once daily
Administration
Palmitoyl Tetrapeptide-7
Topical
Acetyl Hexapeptide-3 (Argireline)
Topical
Cycle Length
Palmitoyl Tetrapeptide-7
Ongoing/indefinite
Acetyl Hexapeptide-3 (Argireline)
Ongoing/indefinite
Onset Speed
Palmitoyl Tetrapeptide-7
Moderate (1-2 weeks)
Acetyl Hexapeptide-3 (Argireline)
Moderate (1-2 weeks)
Evidence Level
Palmitoyl Tetrapeptide-7
Limited human trials
Acetyl Hexapeptide-3 (Argireline)
Limited human trials
Efficacy
Benefit
ratings
Anti-Inflammatory
Anti-Aging
Skin Barrier Support
Expression Wrinkle Reduction
Non-Invasive Treatment
Safety Profile
Technical Data
Compound
specifications
Palmitoyl Tetrapeptide-7
Molecular Formula
C34H62N8O7
Molecular Weight
694.9 Da
Half-Life
Susceptible to enzymatic degradation; palmitoyl anchor reduces proteolytic cleavage rate compared to unmodified peptide
Bioavailability
Enhanced topical penetration via palmitoyl lipid modification enabling membrane interaction and dermal delivery
CAS Number
221227-05-0
Acetyl Hexapeptide-3 (Argireline)
Molecular Formula
C35H62N14O11S
Molecular Weight
887.0 Da
Half-Life
Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
Bioavailability
Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
CAS Number
616204-22-9
Applications
Best
suited for
Palmitoyl Tetrapeptide-7
Individuals with aging skin showing signs of chronic low-grade inflammation
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with aging skin showing signs of chronic low-grade inflammation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those seeking to reduce UV-damage-related skin aging (photoaging)
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on those seeking to reduce uv-damage-related skin aging (photoaging). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking for synergistic peptide therapy in Matrixyl 3000 products
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on people looking for synergistic peptide therapy in matrixyl 3000 products. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides
Palmitoyl Tetrapeptide-7 is particularly well-suited for individuals focused on individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Acetyl Hexapeptide-3 (Argireline)
Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with needle phobia who want botulinum toxin-like effects without injections
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People targeting crow's feet, forehead lines, and glabellar creases
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety Profile
Side
effects
Palmitoyl Tetrapeptide-7
Common
- Mild Redness
- Slight Tingling
- Mild Irritation with Other Actives
- Dryness
Uncommon
- Allergic Contact Dermatitis
Serious
- Paradoxical Inflammatory Response
Acetyl Hexapeptide-3 (Argireline)
Common
- Mild Skin Irritation
- Transient Redness
- Slight Dryness
- Stinging on Compromised Skin
Uncommon
- Contact Dermatitis
Serious
- Allergic Contact Dermatitis
Research Status
Safety
& evidence
Palmitoyl Tetrapeptide-7
Evidence Level
Limited human trials
FDA Status
Research compound
Safety Overview
Palmitoyl tetrapeptide-7 (Eyeliss) shows excellent safety for periocular use with minimal irritation potential (Draize score <0.5 at 2% concentration). No serious adverse events in cosmetic formulations used for 15+ years. Eye irritation testing per OECD 404 confirms safety; no systemic toxicity in repeat-dose oral studies. Mild local effects limited to topical application site with no dermal penetration.
Contraindications
- xKnown hypersensitivity to palmitoyl tetrapeptide-7 or formulation excipients
- xActive skin infections at the application site
- xSeverely compromised skin barrier with active inflammation requiring medical intervention
- xNo known systemic contraindications at cosmetic concentrations
Acetyl Hexapeptide-3 (Argireline)
Evidence Level
Limited human trials
FDA Status
Research compound
Safety Overview
Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. The peptide shows a safety margin of approximately 100-fold compared to toxic reference compounds. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.
Contraindications
- xKnown hypersensitivity to acetyl hexapeptide-3 or formulation components
- xActive skin infections or open wounds at the application site
- xNo known systemic contraindications at cosmetic concentrations
- xUse with caution in individuals with neuromuscular disorders (theoretical concern)
Decision Guide
Which is
right for you?
Choose Palmitoyl Tetrapeptide-7 if...
- Individuals with aging skin showing signs of chronic low-grade inflammation
- Those seeking to reduce UV-damage-related skin aging (photoaging)
- People looking for synergistic peptide therapy in Matrixyl 3000 products
- Individuals with sensitive or reactive skin benefiting from anti-inflammatory peptides
Choose Acetyl Hexapeptide-3 (Argireline) if...
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Those with needle phobia who want botulinum toxin-like effects without injections
- People targeting crow's feet, forehead lines, and glabellar creases
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation